Adverse perinatal conditions and the inner ear

Seminars in Neonatology

Volumn 6, Issue 6, 2001, Pages 543-551

  Newton, Valerie ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Perinatal; Sensorineural hearing impairment

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; DIURETIC AGENT;

ARTICLE; EAR DISEASE; EXPERIENCE; GENE MUTATION; HEARING IMPAIRMENT; HUMAN; HYPERBILIRUBINEMIA; INNER EAR; LOW BIRTH WEIGHT; MENINGITIS; OTOTOXICITY; PERCEPTION DEAFNESS; PERINATOLOGY; RISK FACTOR;

EID: 0035560629     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1053/siny.2001.0076     Document Type: Article

References (56)

1. Aetiology of bilateral sensori-neural hearing loss in young children
2. Longitudinal study of hearing-disabled children. A follow-up investigation
3. Epidemiology of permanent hearing impairment in Trent Region, 1985-1993
4. Risk factors for childhood sensorineural hearing loss in the Oxford region
5. Auditory brainstem response in neonates with hypoxic-ischemicencephalopathy following perinatal asphyxia
6. Screening audiometry using the high-risk register in a level III nursery
7. A public health perspective on childhood hearing impairment
8. Hearing loss in very preterm and very low birthweight infants at the age of 5 years in a nationwide cohort
9. Neonatal screening for hearing disorders in infants at risk: Incidence, risk factors, and follow-up
10. Joint Committee on Infant Hearing 1994 Position Statement
11. Neonatal asphyxia, definitive markers and hearing loss
12. Sensorineural hearing loss and prematurity
13. Outcome to five years of age of children born 24-26 weeks gestational age in Victoria
14. Relative and attributable risks for moderate to profound bilateral sensorineural hearing impairment associated with lower birth weight in children 3-10 years old
15. Functional limitations and special health care needs of 10-to-14-year-old children weighing less than 750 grams at birth
16. Hypoxic-ischemic brain damage in the term infant: Lessons from the laboratory
17. Correlation of clinical findings and timing of the asphyxial event
18. Acute neonatal morbidity and long-term central nervous system sequelae of perinatal asphyxia in term infants
19. Long-term follow-up of term infants with perinatal asphyxia
20. Hearing, speech and language in survivors of severe perinatal asphyxia
21. Adverse perinatal factors in the causation of sensorineural hearing impairment in young children
22. Long-term effect of perinatal and postnatal asphyxia on developing human auditory brainstem responses: Peripheral hearing loss
23. Perinatal asphyxia, hypoxia, ischemia and hearing loss. An overview
24. Antecedents of cerebral palsy. Multivariant analysis of risk
25. Neonatal hyperbilirubinaemia
26. Bilirubin index: A new standard for intervention?
27. MR findings in a patient with kemicterus
28. Hyperbilirubinaemia in low birthweight infants and outcome at five years of age
29. Neonatal hyperbilirubinemia and long-term outcome: Another look at the Collaborative Perinatal Project
30. Audiologic evaluation of neonats with severe hyperbilirubinemia using transiently evoked otoacoustic emissions and auditory brainstem responses
31. Fifteen years of experience with bacterial meningitis
32. A human temporal bone study of acute bacterial meningogenic labyrinthitis
33. Hearing loss during bacterial meningitis
34. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomised clinical trials since 1988
35. Dexamethosone therapy for children with bacterial meningitis
36. Temporal bone studies of the human peripheral vestibular system. Aminoglycoside ototoxicity
37. Sound needs melanocytes to be heard
38. Ototoxicity of vancomycin and anologues
39. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness
40. Otoacoustic emissions-an approach for monitoring aminoglycoside induced ototoxicity in children
41. Neonatal sensorineural hearing loss associated with furosemide: A case controlled study
42. Effects of incubator noise on the cochlea of the newborn
43. Premature infant responses to noise reduction by earmuffs: Effect on behavioural and physiologic measures
44. Interaction between sound and gentamycin: Immediate threshold and stereociliary changes
45. School performance of survivors of neonatal encephalopathy associated with birth asphyxia at term
46. Long time follow-up of term neonates with perinatal asphyxia
47. Neurosensory hearing loss in neonates with severe hypoxemia
48. Idiopathic deafness or hearing loss of unknown etiology following discharge from the NICU
49. Hearing loss in very low birthweight infants treated with neonatal intensive care
50. Perinatal risk factors in the aetiology of hearing loss in preschool children
51. Cause of hearing loss in the high-risk premature infant
52. Neonatal screening with auditory brainstem responses: Results of follow-up audiometry and risk factor evaluation
53. Four factors that accurately predict hearing loss in 'high risk' neonates
54. Neonatal status and hearing loss in high-risk infants
55. Hyponatremia and sensorineural hearing loss in preterm infants